These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN. EVANS JS; BOSTWICK L; MENGEL GD Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140 [No Abstract] [Full Text] [Related]
11. SYNTHESIS OF ISOTHIOCYANATES AS POTENTIAL ANTINEOPLASTIC AGENTS. BURCKHALTER JH; BARIANA DS J Med Chem; 1963 Mar; 6():203-5. PubMed ID: 14188797 [No Abstract] [Full Text] [Related]
12. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS. BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900 [No Abstract] [Full Text] [Related]
13. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE. BRADNER WT; BACHMAN S; PINDELL MH Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273 [No Abstract] [Full Text] [Related]
14. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. 8. VENDITTI JM; KLINE I; GOLDIN A Cancer Res; 1964 Jul; 24():827-79. PubMed ID: 14204394 [No Abstract] [Full Text] [Related]
15. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563 [TBL] [Abstract][Full Text] [Related]
16. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT. JOHNSON RE; ZELEN M; KEMP NH J Natl Cancer Inst; 1965 Feb; 34():277-90. PubMed ID: 14293793 [No Abstract] [Full Text] [Related]
17. Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole. Hahn MA; Adamson RH J Natl Cancer Inst; 1972 Mar; 48(3):783-90. PubMed ID: 4621741 [No Abstract] [Full Text] [Related]
18. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII. VENDIITI JM; SHELDON DR; GOLDIN A Cancer Res; 1964 Jan; 24():145-96. PubMed ID: 14106543 [No Abstract] [Full Text] [Related]
19. AN EXPERIMENTAL THERAPEUTIC APPROACH TO L1210 LEUKEMIA IN MICE: COMBINED CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION. JOHNSON RE J Natl Cancer Inst; 1964 Jun; 32():1333-41. PubMed ID: 14191403 [No Abstract] [Full Text] [Related]
20. SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. IV. AZIRIDINE DERIVATIVES. TSOU KC; HOEGERLE K; SU HC J Med Chem; 1963 Jul; 6():435-9. PubMed ID: 14184901 [No Abstract] [Full Text] [Related] [Next] [New Search]